Genome Institute of Singapore-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8013392)
◆英語タイトル:Genome Institute of Singapore - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013392
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:30
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥52,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥78,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Genome Institute of Singapore (GIS) is a research institute that provides various research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It handles the latest in technology and comprises early career researchers such as next generation sequencing, high-throughput biology, genome engineering, genotyping, cytogenetics and single cell genomics, among others. GIS performs research in human genomics, cancer genomics, infectious diseases, genomics technologies, cancer stem cell biology, tissue regeneration and computational biology areas, among others. The institute offers its services to PhD, MD and M.B.B.S. graduates through its GIS Fellow Programs, to carry their research projects. GIS is headquartered in Singapore.

Genome Institute of Singapore – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genome Institute of Singapore, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Genome Institute of Singapore, Medical Devices Deals, 2011 to YTD 2017 9
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Atreca Enters into Agreement with Genome Institute of Singapore 11
InvitroCue Enters into Research Agreement with Genome Institute of Singapore 12
PerkinElmer Forms Joint Venture with Genome Institute of Singapore 13
Genome Institute of Singapore Extends Research Agreement with Pacific Biosciences 14
Genome Institute of Singapore Enters Into Agreement With Oxford Biodynamics For Stem Cell Epigenetic Signatures 15
Genome Institue of Singapore Partners With Fluidigm To Establish Single-Cell Genomics Research Center 16
Appistry Enters Into Co-Development Agreement With Genome Institute of Singapore 17
Genome Institute of Singapore – Key Competitors 18
Genome Institute of Singapore – Key Employees 19
Genome Institute of Singapore – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 20
Recent Developments 21
Strategy And Business Planning 21
Jul 24, 2017: Launch of New Joint Innovation Laboratory to Advance Personalised Medicine for Cancer Treatment 21
Government and Public Interest 22
Jul 29, 2016: Singapore Scientists Grow Mini Human Brains 22
Jul 18, 2016: Singapore scientists discover new pathways leading to cancer progression 24
Jun 23, 2016: Scientists discover unsuspected bacterial link to bile duct cancer 26
Jun 03, 2016: Novel study on histones provides better understanding of gene regulation 27
Apr 11, 2016: Discovered Genes Reveal Novel Insights into Biology of Glaucoma 28
Product News 29
May 13, 2016: New technique paves the way for drug targeting to fight microbial resistance 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Key Facts 2
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genome Institute of Singapore, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genome Institute of Singapore, Deals By Therapy Area, 2011 to YTD 2017 8
Genome Institute of Singapore, Medical Devices Deals, 2011 to YTD 2017 9
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Atreca Enters into Agreement with Genome Institute of Singapore 11
InvitroCue Enters into Research Agreement with Genome Institute of Singapore 12
PerkinElmer Forms Joint Venture with Genome Institute of Singapore 13
Genome Institute of Singapore Extends Research Agreement with Pacific Biosciences 14
Genome Institute of Singapore Enters Into Agreement With Oxford Biodynamics For Stem Cell Epigenetic Signatures 15
Genome Institue of Singapore Partners With Fluidigm To Establish Single-Cell Genomics Research Center 16
Appistry Enters Into Co-Development Agreement With Genome Institute of Singapore 17
Genome Institute of Singapore, Key Competitors 18
Genome Institute of Singapore, Key Employees 19
Genome Institute of Singapore, Joint Venture 20

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Genome Institute of Singapore-製薬・医療分野:企業M&A・提携分析(Genome Institute of Singapore - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆